AS
Adesh Srivastava
About Adesh Srivastava
Data last updated:
Adesh Srivastava is a Director at Redicare Pharma Private Limited (since 2011). The company operates in Healthcare. Redicare Pharma Private Limited reported revenue of ₹3.43 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Redicare Pharma Private Limited U51909DL2011PTC225352 | Director | 22 Sep 2011 | 2011 | ₹3.43 Cr (FY 2025) | Active |
Board colleagues of Adesh Srivastava
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ravi Kant Srivastava | 03608737 | Redicare Pharma Private Limited | Director |
| Sushil Srivastav | 03608541 | Redicare Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Adesh Srivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Adesh Srivastava
Adesh Srivastava currently holds 1 directorship: Redicare Pharma Private Limited (Director, since 22 Sep 2011, revenue ₹3.43 Cr (FY 2025)).
Adesh Srivastava was first appointed on 22 Sep 2011 as Director at Redicare Pharma Private Limited.
The current boards of Adesh Srivastava's companies include Ravi Kant Srivastava (Redicare Pharma Private Limited), Sushil Srivastav (Redicare Pharma Private Limited).